威爾斯親王醫院，簡稱威院，是一所位於香港新界沙田區沙田圓洲角提供第三層醫護服務的大型公立全科醫院，亦是香港兩所教學醫院之一，為香港中文大學的教學醫院。

During the past decade, Department of Medicine & Therapeutics, Prince of Wales Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Medicine & Therapeutics, Prince of Wales Hospital" #1 sponsor was "Chinese University of Hong Kong" with 20 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Medicine & Therapeutics, Prince of Wales Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Prince of Wales Hospital, Shatin, Hong Kong" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Medicine & Therapeutics, Prince of Wales Hospital" are "Rheumatoid Arthritis" (3 trials), "Alzheimer's Disease" (2 trials), "Atrial Fibrillation" (2 trials), "Crohn's Disease" (2 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Department of Medicine & Therapeutics, Prince of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Department of Medicine & Therapeutics, Prince of Wales Hospital" are "Drug" (24 trials), "Device" (5 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Filgotinib" (3 trials), "Crenezumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Department of Medicine & Therapeutics, Prince of Wales Hospital" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Department of Medicine & Therapeutics, Prince of Wales Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Department of Medicine & Therapeutics, Prince of Wales Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Medicine & Therapeutics, Prince of Wales Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".